Dose dense neoadjuvant and adjuvant chemotherapy in triple-negative breast cancer patients: Survival analysis

AbstractThis manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.

Download Full-text

Survival analysis of triple negative breast cancer patients treated with Anthracycline based chemotherapy: A Retrospective Study from Central part of India

IP Journal of Diagnostic Pathology and Oncology ◽

10.18231/j.jdpo.2020.002 ◽

2020 ◽

Vol 5 (1) ◽

pp. 9-12

Author(s):

Dheerendra Kumar Sachan ◽

◽

Abhishek Shrivastava ◽

Ruchita Sachan ◽

Varsha Mandloi ◽

...

Keyword(s):

Breast Cancer ◽

Survival Analysis ◽

Retrospective Study ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Patients

Download Full-text

Prolonged Time to Adjuvant Chemotherapy Initiation Was Associated with Worse Disease Outcome in Triple Negative Breast Cancer Patients

Scientific Reports ◽

10.1038/s41598-020-64005-4 ◽

2020 ◽

Vol 10 (1) ◽

Author(s):

Lifen Cai ◽

Yiwei Tong ◽

Xiaoping Zhu ◽

Kunwei Shen ◽

Juanying Zhu ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Disease Outcome ◽

Breast Cancer Patients ◽

Prolonged Time ◽

Chemotherapy Initiation

Download Full-text

Genetic polymorphisms of autophagy-related gene 5 (ATG5) rs473543 predict different disease-free survivals of triple-negative breast cancer patients receiving anthracycline- and/or taxane-based adjuvant chemotherapy

Chinese Journal of Cancer ◽

10.1186/s40880-018-0268-1 ◽

2018 ◽

Vol 37 (1) ◽

Cited By ~ 4

Author(s):

Meiying Li ◽

Fei Ma ◽

Jiayu Wang ◽

Qing Li ◽

Pin Zhang ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Genetic Polymorphisms ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Patients ◽

Related Gene ◽

Disease Free

Download Full-text

Polymorphisms in AURKA and AURKB are associated with the survival of triple-negative breast cancer patients treated with taxane-based adjuvant chemotherapy

Cancer Management and Research ◽

10.2147/cmar.s174735 ◽

2018 ◽

Vol Volume 10 ◽

pp. 3801-3808 ◽

Cited By ~ 6

Author(s):

Yuqian Liao ◽

Yulu Liao ◽

Jun Li ◽

Junyu Li ◽

Ying Fan ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Patients

Download Full-text

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients

International Journal of Oncology ◽

10.3892/ijo.2018.4241 ◽

2018 ◽

Cited By ~ 3

Author(s):

Magdalena Absmaier ◽

Rudolf Napieralski ◽

Tibor Schuster ◽

Michaela Aubele ◽

Axel Walch ◽

...

Keyword(s):

Breast Cancer ◽

Dna Methylation ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Breast Cancer Patients

Download Full-text

Abstract OT-13-10: Global Phase 3 Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy

10.1158/1538-7445.sabcs20-ot-13-10 ◽

2021 ◽

Author(s):

Hope Rugo ◽

Louis W.C. Chow ◽

Javier Cortes ◽

Peter A. Fasching ◽

Xu-Bing He ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Triple Negative Breast Cancer ◽

Triple Negative ◽

Early Stage ◽

Placebo Treatment ◽

Breast Cancer Patients ◽

Phase 3

Download Full-text